Elsevier

Biochemical Pharmacology

Volume 21, Issue 24, 15 December 1972, Pages 3287-3299
Biochemical Pharmacology

Inhibition of hepatic oxidative xenobiotic metabolism by piperonyl butoxide

https://doi.org/10.1016/0006-2952(72)90093-7Get rights and content

Abstract

The oxidative metabolism of piperonyl butoxide to a metabolite which forms a complex with reduced cytochrome P-450 is not inhibited by cyanide, but is prevented by the mercurial mersalyl. The apparent Km for this oxidation of piperonyl butoxide is low, being 65 μM. The inhibition of ethylmorphine N-demethylation by piperonyl butoxide in vitro is proportional to the amount of cytochrome P-450 present as the cytochrome P-450-piperonyl butoxide metabolite complex. Piperonyl butoxide shows mixed inhibition kinetics when present during ethylmorphine N-demethylation, i.e. competitive during the formation of the piperonyl butoxide metabolite, and noncompetitive once the metabolite is complexed with cytochrome P-450. Differences in the rate of formation of the piperonyl butoxide metabolite-cytochrome P-450 complex in liver microsomes from rats and mice can account for the greater sensitivity of mice to piperonyl butoxide inhibition of drug metabolism. Enhancement of absorption spectra in turbid solutions, such as piperonyl butoxide dispersions, is examined and discussed.

References (14)

  • F.X. Kamienski et al.

    Biochem. Pharmac.

    (1970)
  • P.S. Graham et al.

    Biochem. Pharmac.

    (1970)
  • R.M. Philpot et al.

    Life Sci.

    (1971)
  • M. Anders

    Biochem. Pharmac.

    (1968)
  • B.S.S. Masters et al.

    J. biol. Chem.

    (1971)
  • E.G. Esaac et al.

    J. agric. Fd. Chem.

    (1969)
  • M.R. Franklin

    Xenobiotica

    (1971)
There are more references available in the full text version of this article.

Cited by (0)

Present address: Department of Biopharmaceutical Sciences, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112.

View full text